Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of PIKA COVID-19 Vaccine Booster in Adults
NCT05463419Phase 3Completed
- Sponsor
- LakeShore Biopharma Co., Ltd
- Start
- Oct 2022
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of PIKA COVID-19 vaccine in coronavirus disease 2019 (COVID-19), sponsored by LakeShore Biopharma Co., Ltd. Started Oct 2022; status: completed.
02
Drugs
PIKA COVID-19 vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05463419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05463419.